Back
to sessions
Sep 28
Poster Q & A
MODERATOR(S)
Neha Vapiwala, MD, FASTRO, FASCO, FACR - University of Pennsylvania
Presentations
-
04:00pm - 05:00pm ET
Prognostic Impact of Comprehensive Genomic Profiling Stratified by <em>STK11</em> Status in NSCLC Treated with the PACIFIC Regimen
Speaker: Levi Martinka, MD - Moffitt Cancer Center, Tampa -
04:00pm - 05:00pm ET
Low-Dose Hypofractionated Bridging Radiation (4Gy x 2 Fractions) Prior to CAR T-Cell Therapy for Relapsed/Refractory DLBCL
Speaker: Jonathan Baron, MD - University of Pennsylvania, Philadelphia -
04:00pm - 05:00pm ET
Dosimetric Outcomes and Clinical Toxicity from CT-Based Online Adaptive Hypofractionated Radiotherapy for Non-Operable Pancreatic Cancer
Speaker: John Peterson, MD - H. Lee Moffitt Cancer Center and Research Institute, Tampa -
04:00pm - 05:00pm ET
Expert Validation of Large Language Model Triage Predictions for Radiation Oncology Incident Learning System Forms
Speaker: Stephen Gardner, MS - Henry Ford Health System, Charter Township of Clinton -
04:00pm - 05:00pm ET
Clinical Validation of Dose Regimen Generalized AI Prostate SBRT Plans: Dosimetric Comparison, Blinded Physician Review, and Deliverability Assessment
Speaker: Nayoon Lee, BA - University of Pennsylvania, Philadelphia -
04:00pm - 05:00pm ET
ctDNA Evaluation on a Phase I Trial of Pre-Operative Ablative Radiation for Early Stage Hormone Positive Breast Cancer
Speaker: Asal Rahimi, MD, MS - University of Texas Southwestern Medical Center at Dallas, Dallas -
04:00pm - 05:00pm ET
Quantifying Clinical Intuition in oART: Survey-Derived Development and Retrospective Validation of a Web-Based Adaptive Benefit Framework for Online Adaptive Radiotherapy
Speaker: Dennis Stanley, PhD - The University of Alabama at Birmingham, Birmingham -
04:00pm - 05:00pm ETSpeaker: Suraj Pai, PhD - Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston
-
04:00pm - 05:00pm ETSpeaker: Madeline Evans, BS - UAB Heersink School of Medicine, Birmingham
-
04:00pm - 05:00pm ET
Deep Learning-Enabled IMPT Treatment Planning Using a Current Clinical Setup: Principles and Validation Toward Online Adaptive Proton Therapy
Speaker: Zhiyong Yang, - Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan -
04:00pm - 05:00pm ET
Acute-Phase Semiquantitative Immune Cell Kinetics as Multi-Endpoint Prognostic Biomarkers for Survival Metrics in LA-NSCLC treated with Chemoradiotherapy
Speaker: Ying Xiao, PhD, FASTRO - University of Pennsylvania, Philadelphia